Advertisement
Canada markets open in 8 hours 24 minutes

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7325
    +0.0002 (+0.02%)
     

  • CRUDE OIL

    83.86
    +0.29 (+0.35%)
     

  • Bitcoin CAD

    87,535.20
    -177.56 (-0.20%)
     

  • CMC Crypto 200

    1,388.46
    +5.88 (+0.43%)
     

  • GOLD FUTURES

    2,347.50
    +5.00 (+0.21%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,764.25
    +196.75 (+1.12%)
     

  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • NIKKEI 225

    38,045.02
    +416.54 (+1.11%)
     

  • CAD/EUR

    0.6829
    +0.0008 (+0.12%)
     

Tilray Rose 13% Today after Falling for Six Days

John Parker
Updated
Tilray Rose 13% Today after Falling for Six Days

After the news of Tilray’s intention to purchase hemp-derived CBD isolate from LiveWell Canada came out, Tilray stock rose more than 13% on December 18. At 9:50 AM EST on December 18, Tilray stock posted a day high of $74.69—up 13.4% from the previous session’s closing price. Last week, Tilray announced its investments in ROSE LifeScience.

Continue reading